ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 285233 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 285233; 2) Community: the network communities that were significantly associated with the response to NSC 285233; 3) Molecule: the relationships between components within communities and NSC 285233; 4) MDR: the compounds that were significantly associated with the NSC 285233.

NSC Compound Enrichment Correlation
NSC 702134 Null 0.0462077035966091 0.45475994
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.0462077035966091 0.25521359
NSC 102627 Yoshi 864 0.0467178916101838 0.19157022
NSC 10660 Null 0.0467178916101838 0.22806085
NSC 137765 Ethanesulfonic acid, compd. with 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-N-phenylbenzeneacetamide (1:1) 0.0467178916101838 -0.048665869
NSC 145219 Null 0.0467178916101838 0.33328982
NSC 153325 Null 0.0467178916101838 0.39923116
NSC 17065 Null 0.0467178916101838 0.10259642
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.0467178916101838 0.53195716
NSC 191909 .alpha.-Chloro-N-(p-methoxyphenyl)succinimide 0.0467178916101838 0.40312508
Total:62  Current:58    [First] [Prev] [Next] [Last]